Skip to content
2000
Volume 10, Issue 4
  • ISSN: 1871-5222
  • E-ISSN: 1875-6115

Abstract

Myostatin is a member of the transforming growth factor β superfamily of secreted growth factors that negatively regulates skeletal muscle size. Mice null for the myostatin gene have a dramatically increased mass of individual muscles, reduced adiposity, increased insulin sensitivity, and resistance to obesity. Myostatin inhibition in adult mice also increases muscle mass which raises the possibility that anti-myostatin therapy could be a useful approach for treating diseases such as obesity or diabetes in addition to muscle wasting diseases. In this review I will describe the present state of our understanding of the role of myostatin and the closely related growth factor growth/differentiation factor 11 on metabolism.

Loading

Article metrics loading...

/content/journals/iemamc/10.2174/187152210793663810
2010-12-01
2025-09-11
Loading full text...

Full text loading...

/content/journals/iemamc/10.2174/187152210793663810
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test